Floatz logo

Therapeutic Asset Ratings

603 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Hpc, Cord Blood
Lymphoma
Memorial Sloan Kettering Cancer CenterP2CCC (54)
LEUPROLIDE
Myelodysplastic Syndrome
Memorial Sloan Kettering Cancer CenterP2CCC (54)
Cyclophosphamide
Pleural Cancer
Memorial Sloan Kettering Cancer CenterP1/2CCC (54)
Pembrolizumab
Basal Cell Carcinoma
Memorial Sloan Kettering Cancer CenterP1/2CCC (54)
Mifepristone
Breast Cancer
Memorial Sloan Kettering Cancer CenterP3CCC (53)
Anti-Thymoglobulin, Rabbit
Thalassemia
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Anti-Thymoglobulin, Rabbit
Beta Thalassemia
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Arimidex
Lobular Breast Carcinoma
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Azacitidine
Plasmacytoma
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Azacitidine
Solitary Osseous Plasmacytoma
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Bio 300
Interstitial Lung Disease
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Bms-907351
Fumarate Hydratase Deficient Renal Cell Carcinoma
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Bortezomib
Monoclonal Gammopathy of Renal Significance
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Bortezomib
Thalassemia
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Bortezomib
Beta Thalassemia
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Busulphan
Hemophagocytic Syndrome
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Busulphan
Hemophagocytic Lymphohistiocytosis
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Busulphan
Inborn Errors Of Metabolism
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Busulphan
NHL or HL
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Capecitabine
Clinical Stage: Stage II (T3-4, N-)
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Capecitabine
Stage III (Any T, N+)
Memorial Sloan Kettering Cancer CenterP2CCC (53)
cc-5013
Solitary Osseous Plasmacytoma
Memorial Sloan Kettering Cancer CenterP2CCC (53)
CIS-DIAMMINEDICHLOROPLATINUM II
Monoclonal Gammopathy of Renal Significance
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Clindamycin
Toxic Dermatosis
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Clofarabine
Bone Marrow Failure Syndrome
Memorial Sloan Kettering Cancer CenterP2CCC (53)
Showing 151 to 175 of 603 assets
PreviousPage 7 of 25Next